LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...
Cochlear reaffirmed guidance for FY 2025 underlying net profit between $410 million and $430 million, though it expects to achieve the lower end of this range. The revision is driven by weaker ...
The Nucleus 8 Sound Processor is the world's first cochlear implant sound processor ready for Bluetooth LE Audio technology Experience the full interactive ...
Cochlear Ltd. heard good news from the U.S. FDA, as the agency approved its next-generation cochlear implant, the Nucleus Nexa System, the first smart cochlear implant system. Cochlear expects to ...
DUBLIN--(BUSINESS WIRE)--The "Cochlear Implants Market" report has been added to ResearchAndMarkets.com's offering. Valued at nearly $1.2bn in 2018, the Cochlear Implants Market is growing at a ...
The recent report, Global Cochlear Implants Market 2022-2028, by Coherent Market Insights, provides a comprehensive assessment of the market landscape, including both the current and future market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results